1. United States Pharmacopoeia (USPXXI) (National Formulary), 1291–1421.
2. British Parmacopoeia. Her Majesty′s Stationary Office, London, 1993, pp. 547–586.
3. Real Farmacopea Española. Ministerio de Sanidad y Consumo, Madrid, 1997, pp. 1601–1720.
4. CPMP, Committee for Proprietary Medicinal Products, Note on guidance on the Investigation of bioavailability and bioequivalence. The European Agency for the Evaluation of Medicinal products, 1998.
5. FDA, Food and Drug Aministration. Guidance for Industry. Dissolution testing of immediate release solid dosage oral forms. US Department of Health and Human Services. Center for drug Evaluation and Research, Washington, 1997